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RÉSUMÉ 
 
Dans la présente étude, nous avons évalué quantitativement 
l’hémodynamique de la circulation choroïdienne subfovéolaire chez des 
patients atteints de glaucome à angle ouvert et des patients présentant une 
hypertension oculaire. Nous avons étudié l'effet des facteurs de risque du 
glaucome sur la circulation choroïdienne subfoveale en vue de déterminer 
le rôle de cette circulation dans la pathogénie de cette maladie. De plus, 
nous avons établi les relations entre les paramètres hémodynamiques et 
un nombre de paramètres physiologiques tels que l'âge, la pression 
intraoculaire et la pression de perfusion oculaire.  
Les résultats de cette étude indiquent clairement que des altérations 
de l'hémodynamique choroïdienne subfoveale sont présentes chez les 
patients atteints de glaucome et d'hypertension oculaire. Ils permettent 
également de conclure que la circulation choroïdienne est déjà altérée 
chez les patients présentant des facteurs de risque de glaucome tels que le 
diabète, l'hypertension systémique et la myopie.   
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Introduction 
 
INTRODUCTION  
 
Le glaucome, une des causes principales de la cécité dans le 
monde, est caractérisé par la perte progressive de fibres nerveuses  
combinée à une excavation de la tête du nerf optique dont les 
conséquences sont  une  perte plus ou moins grave du champ visuel 
(Tielsh, 1991). Bien que la description clinique du glaucome soit bien 
établie, le mécanisme causal exact n'est toujours pas établi. En plus de 
l’augmentation de la pression intraoculaire (PIO), qui est un facteur de 
risque établi, beaucoup d'autres facteurs de risque ont été décrits, tels que 
l’âge et les antécédents familiaux. Il est de plus en plus évident que 
d'autres facteurs déterminent le déclanchement, la sévérité, le cours, et les 
conséquences de la maladie. En particulier, comment expliquer les 
altérations progressives en dépit d'une PIO normale? Pour répondre à 
cette question, il est nécessaire de considérer d'autres facteurs de risque 
liés à la neuropathie du nerf optique dans le glaucome, en particulier 
l'insuffisance vasculaire (Gasser, 1998).  
Il est connu de nos jours qu’un certain nombre de patients 
glaucomateux sont aussi atteints de maladies vasculaires oculaires ou 
systémiques (Emre et al., 2004). Par conséquent, il est important de 
déterminer si ces maladies affectent l'hémodynamique oculaire dans les 
yeux glaucomateux. Dans ce but nous avons analysé des groupes de 
sujets présentant des facteurs de risque présents dans un nombre 
important de patients glaucomateux, tels que l'hypertension systémique, 
le diabète et la myopie. Les mesures hémodynamiques sur ces sujets non 
glaucomateux ont été comparés à celles obtenues dans un groupe de 
patients atteints de glaucome ayant les mêmes facteurs de risque. Ceci 
nous a permis d’évaluer l'effet du glaucome sur l'hémodynamique 
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oculaire chez les  patients présentant diverses pathologies considérées 
comme facteurs de risque du glaucome.  
Le diabète, l'hypertension systémique et la myopie ont été 
sélectionnés pour les raisons suivantes :  
  Ces pathologies sont souvent associées au glaucome. 
  leur rôle dans les altérations ou la progression du glaucome est 
controversé.    
  le traitement du diabète et de l'hypertension systémique peut affecter 
la progression du glaucome. 
Un grand nombre d'études cliniques ont examiné la circulation 
rétrobulbaire chez les patients glaucomateux (Akarsu et Bilgili, 2004 ; 
Bout et al., 1997 ; Cheng et al., 2001 ; Galassi et al., 1992 ; Klemm et 
Zeitz, 2006 ; Nicolela et al., 1996a), ainsi que celle de la tête de nerf 
optique et de la région péripapillary (Chung et al., 1999 ; Grunwald et 
al., 1999 ; Hafez et al., 2003 ; Hamard et al., 1994 ; Michelson et al., 
1996 ; Piltz-Seymour, 1999 ; Piltz-seymour et al., 2001 ; Riva et al., 
2004). En revanche, très peu d'études ont été consacrées à 
l'hémodynamique choroïdienne chez ces patients (Emre et al., 2004 ; 
Grunwald et al., 1998b). En particulier le manque de données sur 
l’hémodynamique dans les vaisseaux de la choroïde subfoveale, le 
système vasculaire qui nourrit la région la plus importante de la rétine, à 
savoir la fovéa, représente une lacune importante dans notre connaissance 
de la pathogénie du glaucome. Pour remédier à cette lacune, nous avons 
entrepris une étude dont le but fût de déterminer le débit sanguin 
choroïdien subfovéolaire.  
La mesure du débit  choroïdien chez l’homme  exige une technique 
non invasive qui soit aussi sensible, précise et reproductible pour  pouvoir 
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détecter les changements pathologiques encore à un stade précoce de la 
maladie (Petrig et Riva, 1999).  
Parmi les diverses techniques appropriées à l’étude de 
l'hémodynamique choroïdienne, la fluxmétrie laser Doppler (LDF) 
satisfait au mieux ces conditions idéales. Les mesures obtenues par LDF 
fournissent des données quantitatives sur le flux sanguin dans les 
choriocapillaires (Riva et al., 1994). De plus la réponse temporelle de la 
LDF permet de démontrer des changements de flux pendant le cycle 
cardiaque. Un avantage de cette technique est qu’elle n’exige pas la 
dilatation de la pupille.  (Riva, 2001).  
Les objectifs de ce travail ont été: a) l’étude du débit choroïdien 
chez les patients atteints de glaucome (glaucome à pression élevée et à 
pression normale ou avec hypertension oculaire); b) l’évaluation des 
effets du diabète, de l'hypertension systémique et de la myopie, tous 
considérés comme facteurs de risque de glaucome, sur ce débit ; c) 
l’établissement de corrélations entre les paramètres hémodynamiques 
obtenus de la circulation choroïdienne subfoveale et données cliniques 
(âge, PIO et pression de perfusion) obtenues d’un groupe de sujets 
normaux et d’un groupe de patients atteints de glaucome.  
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1. INTRODUCTION 
 
Glaucoma, one of the leading causes of blindness in the world, is 
characterized by the presence of chronic optic neuropathy combined with 
characteristic morphological changes at the optic nerve head and 
corresponding visual field defects (European Glaucoma Society, 2003). 
Although the clinical picture of glaucoma is well described, the exact 
causative mechanism has not yet been elucidated. In addition to increased 
intraocular pressure (IOP) which is an established risk factor, many other 
risk factors have been described, such as age, race and family history. 
Increasing evidence suggests that further factors determine onset, 
severity, course, and outcome of the disease. In particular, how can one 
explain progressive glaucomatous optic damage despite a low IOP? To 
answer this question, one must consider other risk factors associated with 
glaucomatous optic neuropathy including vascular insufficiency, the so-
called ‘vascular risk factors’ (Gasser, 1998).  
It is well know nowadays that many glaucoma patients have some 
kind of ocular or systemic vascular diseases (Emre et al., 2004). From 
this point of view, it would be interesting to know how these diseases 
affect the ocular hemodynamics in glaucomatous eyes. Therefore we 
decided to analyze groups of populations who have not glaucoma, but 
who have risk factors found in many glaucoma patients, such as systemic 
hypertension, diabetes mellitus and myopia. These subjects were 
compared to a group of glaucoma patients having the same risk factors. 
This allowed us to evaluate the effect of these risk factors on the ocular 
hemodynamics of the normal population and glaucoma patients. 
A large number of clinical studies have been performed to clarify 
the changes in retrobulbar circulation of glaucomatous patients (Akarsu 
and Bilgili, 2004; Butt et al., 1997; Cheng et al., 2001; Galassi et al., 
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1992; Klemm and Zeitz, 2006; Nicolela et al., 1996a). Also the effect of 
glaucoma on the of optic nerve head and peripapillary blood flow has 
been investigated by many authors (Chung et al., 1999; Grunwald et al., 
1999; Hafez et al., 2003; Hamard et al., 1994; Michelson et al., 1996; 
Piltz-Seymour, 1999; Piltz-seymour et al., 2001; Riva et al., 2004). In 
contrast, we found very few studies on subfoveal choroidal blood flow in 
glaucomatous patients (Emre et al., 2004; Grunwald et al., 1998b). The 
lack of data on the hemodynamic in the subfoveal circulation, the system 
that nourishes the most important region of the retina, namely the fovea 
provided the rationale for our study. Whether glaucoma or its risk factors 
affect the blood flow of the foveal region is an important question from a 
research and clinical standpoint.  
Assessment of choroidal blood flow has been difficult 
experimentally and clinically. Investigation of the choroidal 
hemodynamics in humans requires non-invasive measurement of 
choroidal blood flow. Ideally, the measurement technique should be 
sensitive enough for pathological changes to be detected as early as 
possible. Furthermore, it should be accurate and reproducible and should 
have a response time short enough to follow physiological fluctuations in 
this blood flow (Petrig and Riva, 1999). 
Among the various techniques which have been applied in humans 
to investigate choroidal hemodynamics, laser Doppler flowmetry (LDF) 
is the closest to fulfill the ideal requirements. It is a powerful technique to 
investigate noninvasively changes in blood flow in various ocular tissues 
including the subfoveal choroid. The obtained measurements of choroidal 
LDF correspond primarily to the determination of choriocapillaris flow 
(Riva et al., 1994). This is in contrast to pulsatile ocular blood flow 
(POBF) measurements that represent only the overall pulsatile intraocular 
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blood flow (Silver et al., 1989). The high sensitivity and temporal 
response of the technique allow demonstrating changes in flux during the 
cardiac cycle and in response to changes in various physiological 
parameters such as perfusion pressure, breathing conditions and neuronal 
activity. Furthermore, the near-infrared laser diodes enable measurements 
through undilated pupils (Riva, 2001). 
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2. AIM OF THE WORK 
 
The aims of the work are a) to investigate the choroidal 
hemodynamic changes in patients with glaucoma (high and normal 
tension glaucoma) or ocular hypertension; b) to assess the effects of 
diabetes, systemic hypertension and myopia, all considered as glaucoma 
risk factors, on choroidal hemodynamics; c) to establish correlations 
between hemodynamic parameters obtained from the subfoveal choroidal 
circulation and the clinical findings obtained from the normal population 
and glaucoma patients, such as age, intraocular pressure and perfusion 
pressure. 
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3. REVIEW OF LITERATURE 
 
 
3.1. Definition 
 
Primary open-angle glaucoma (POAG) is a disorder that 
demonstrates typical structural changes in the optic disc along with visual 
field defects related to an abnormal elevation of intraocular pressure 
(IOP) and no obvious causative ocular or systemic conditions. Normal-
tension glaucoma (NTG) is a type of glaucoma that shares clinical 
features and mechanisms with POAG, except for the abnormal elevation 
of IOP (Kiriyama et al., 2003). 
  
  
3.2. Prevalence of Glaucoma Worldwide 
It has been estimated that at the start of year 2010, there will be 
60.5 million people with open angle glaucoma (OAG) and angle closure 
glaucoma (ACG) increasing to 79.6 million by 2020. Bilateral blindness 
will be present in 4.5 million people with OAG in 2010, rising to 5.9 
million people in 2020, making glaucoma the second leading cause of 
blindness worldwide (Quigley and Broman, 2006). It has been 
demonstrated that glaucoma is one of the most frequent diagnosis 
associated with visual disability in the elderly population living in an 
urban area of Geneva region, Switzerland (Donati and Christiaen, 2006). 
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3.3 Pathophysiology 
The exact cause of GON is not known. A detailed discussion of POAG 
must address two fundamental issues: (1) the mechanism (s) of IOP 
elevation, and (2) the mechanism (s) of progressive optic nerve cupping 
and atrophy. 
 
3.3.1. IOP elevation 
It is generally accepted that the increased IOP seen in most cases 
of POAG is caused by a decreased facility of aqueous humor outflow. 
Although there have been a few reports of patients with hyper-secretion 
of aqueous humor (Becker et al., 1956), this condition is exceedingly rare 
and therefore will not be further discussed . 
Many investigators have studied the actual site of outflow 
resistance. The most accepted hypothesis is that the trabecular meshwork 
or the endothelium of Schlemm's canal is the site of the increased 
resistance to outflow in POAG. Several theories have been proposed to 
explain this phenomenon. They are summarized as follows (Stamper et 
al., 1999): 
 
1)  An obstruction of the trabecular meshwork by foreign material. 
2)  A loss of trabecular endothelial cells. 
3)  A reduction in pore density and size in the inner wall endothelium of 
Schlemm's canal. 
4)  A loss of giant vacuoles in the inner wall endothelium of Schlemm's canal. 
5)  A loss of normal phagocytic activity.  
6)  Disturbance of neurological feedback mechanisms. 
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Various investigators have linked the increased resistance to 
outflow with altered corticosteroid metabolism (Armaly, 1963), 
dysfunctional adrenergic control (Becker and Shin, 1976), abnormal 
immunologic processes (Shin et al., 1977) and oxidative damage 
(Coupland et al., 1993). 
3.3.2. Progressive optic nerve cupping and atrophy 
Intense research is currently underway regarding the pathogenetic 
concept of glaucoma, and today's understanding will be complemented or 
even supplemented by new aspects in a few years. In glaucoma, glial cells 
and ganglion cells destruction occurs primarily via a process called 
apoptosis "programmed cell death”, and a major tissue remodeling 
causing, among other effects, the visible optic head excavation, but the 
exact mechanism is largely unknown. IOP is involved in many ways in 
this process. When the IOP is extremely high, the papilla becomes 
mechanically damaged and the axo-plasmic flow is blocked. However, it 
has been supposed that the increased IOP as well as decreased blood 
pressure can lead to reduced perfusion, and this occurs especially in the 
presence of vascular dysregulation (Flammer, 2006a) (Fig. 1).  
Reducing the perfusion below certain limits leads to a shortage of 
oxygen with disturbance in oxidative metabolism in the cytochromes of 
the optic nerve (Novack et al., 1990). However, reduced perfusion is 
rarely so pronounced that it leads to cell death. One hypothesis has 
postulated that the relative oxygen shortage rather causes secondary 
damage during the period when there is a renewed increase in the oxygen 
concentration because free oxygen radicals are produced in this phase 
leading to reperfusion injury (Flammer, 2006a) (Fig. 2). 
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Glutamate concentration can reach toxic levels because oxygen 
free radicals prevent the astrocytes from absorbing glutamate. This 
increased glutamate concentration can thus contribute to ganglion cell 
death. A contemporary hypothesis of possible pathogenic mechanisms 
that underlie GON include excitotoxic damage of peroxynitrite produced 
in the axons as a result of oxidative stress and reperfusion injury together 
with activation of the glial cells by ischemic or mechanical stress 
(Flammer, 2006a). 
 
 
 
 
 
 
 
 
 
Fig. 1. Concept of pathogenesis. Both increased IOP as well as decreased 
blood pressure can lead to glaucomatous damage, especially when 
accompanied by vascular dysregulation (reprinted from Flammer, 2002, with 
permission from the publisher). 
 
 
 
 
 
 
 
Fig. 2. The simultaneous oxidative stress brought about by reperfusion and 
activation of astrocytes leads to the damaging peroxinitrate (reprinted from 
Flammer, 2006a, with permission from the publisher). 
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3.4. Glaucoma risk factors 
 
Risk factors are inherited or inborn characteristics, environmental 
exposures, or aspects of personal behavior that affect the probability of 
individuals to develop the disease (Wilson and Martone, 1996). 
Many risk factors may play an important role and, in certain cases, 
even a predominant role in the pathogenesis of POAG. The quality of 
available data regarding potential risk factors for the glaucoma varies 
among many studies. 
 Hereby, we have attempted to present the risk factors in a graded 
format based on the strength of the supporting evidence (Table 1). 
Table 1. Glaucoma Risk Factors classified according to the strength of supporting evidence
(Wilson, 1997) 
Strong supporting 
evidence 
Fair supporting 
evidence 
Weak supporting evidence 
Intraocular Pressure Myopia Steroids 
Age Diabetes Mellitus Gender 
Family History of 
Glaucoma 
Circulatory problems 
(e.g. blood pressure) 
Trauma 
Race Hypothyroidism Smoking and Alcohol 
Central corneal 
thickness 
Optic disc 
appearance 
Socioeconomic factors  
Blood disorders 
 
In this review, we will only discuss some of the most important 
risk factors of glaucoma. 
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3.4.1. Intraocular pressure (IOP): 
 Elevated IOP is probably the most significant ocular risk factor for 
developing GON (Armaly, 1969). Although no conclusive evidence 
supports this direct correlation, the existing evidence suggests to reveal a 
strong causal effect of IOP in glaucomatous damage (Krakau, 1981). 
A number of reports demonstrated that the prevalence of GON 
rises as IOP increases (Mason et al., 1989) (Fig. 3 a). The incidence of 
GON increases from approximately 3% in patients with an IOP between 
21 and 25 mmHg, to more than 50% in patients whose IOP is higher than 
35 mmHg. The incidence of POAG is also five times greater in patients 
with an IOP higher than 21 mmHg than in those with IOP lower than 21 
mmHg (Armaly et al., 1980; Crichton et al., 1989). Moreover, the causal 
role for IOP in glaucomatous damage was supported experimentally by 
induction of high IOP in animals, which results in typical glaucomatous 
optic nerve cupping (Quigley and Addicks, 1980). 
Lowering the IOP is important in decreasing the rate of progression 
of visual field loss (Mao et al., 1991) and regression of optic nerve and 
visual field damage may occur after substantial IOP lowering (Sogano et 
al., 1993; Wilson and Martone, 1996). However, belief in the importance 
of IOP as a causative factor for POAG is not without contention. Some 
eyes with elevated IOP have no glaucomatous damage while others with 
normal or even low IOP have definite glaucomatous damage. It is 
important to remember that there is no cut-off point to delineate 
"elevated" from "normal" IOP. The lack of a one to one relationship 
between IOP of 21 mmHg or higher and GON, and the occurrence of 
damage despite IOP below 21 mmHg suggest that other factors also 
contribute to the pathogenesis of glaucoma (Krakau, 1981). Therefore, 
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what is considered "safe" or "normal" level of IOP differs from one 
patient to another, depending on the vulnerability of the optic nerve and 
the presence of other risk factors (Dignam and Stutman, 2001). 
 
3.4.2. Age: 
Age has been identified as one of the major risk factors of 
glaucoma (Fig. 3 b). It was reported that persons older than 60 years have 
a risk of developing POAG and visual field defects over a 13-year period 
seven times greater than persons below 40 years (Armaly et al., 1980).  
The exact nature of age-related changes that contribute to the 
development of POAG is not known. The higher IOP noted in older age 
groups is not likely to be the sole explanation because it does not increase 
with age among the Japanese population, although POAG does 
(Leibowitz et al., 1980). Older people have higher incidence of 
pseudoexfoliation, in addition to a higher incidence of vascular accidents, 
which could explain the increased prevalence of POAG with age 
(Chihara et al., 1997). 
. 
 
 
 
 
 
 
 
Fig. 3.  a) The higher the IOP, the more frequently glaucomatous damage level. 
            b) The prevalence of glaucomatous damage increase with the age. 
(reprinted from Flammer, 2006b, with permission from the publisher).  
a b
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3.4.3. Myopia: 
The magnitude of the association between myopia and glaucoma 
differs considerably between studies. Some show a significant association 
between high myopia and prevalent field loss (Mitchell et al., 1999; 
Wilson et al., 1987). Defective connective tissue elements in the optic 
nerve, lamina cribrosa, and scleral shell may result in a shared 
pathogenetic pathway (Chihara et al., 1997). On the other hand, a 
protective effect of myopia for further progression of field damage was 
noted (Phelps, 1982). However, a great potential for such data may be 
influenced by selection bias, since individuals with refractive errors are 
more likely to seek eye care and to be diagnosed early as having 
glaucoma (Quigley et al., 1994). 
Peripheral iris concavity in myopic eyes facilitates irido-zonular 
contact, thereby increasing pigment liberation and the incidence of 
pigmentary dispersion syndrome and pigmentary glaucoma in such eyes 
(Scheie and Cameron, 1981). Impaired retrobulbar (Galassi et al., 1998) 
retinal (Shimada et al., 2004) and choroidal (Karczewicz and 
Modrzejewska, 2004) circulations have been demonstrated in 
glaucomatous eyes associated with high myopia. These abnormalities of 
the ocular circulation might be interpreted as a vascular risk factor for the 
pathogenesis of the GON. 
Recent studies suggest that the myopic eye has an increased 
sensitivity to IOP. This means that someone near-sighted is more likely to 
experience optic nerve damage than an emmetropic individual with the 
same IOP (Mayama et al., 2002).  
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3.4.4. Diabetes Mellitus (DM): 
Whether a positive association between DM and glaucoma exists is 
still debatable. Although a number of studies has failed to confirm an 
association between diabetes and glaucoma (Armaly et al., 1980; Ellis et 
al., 2000; Jonas and Grundler, 1998; Tielsch et al., 1995a), reports from 
several investigators support such an association. The Beaver Dam Eye 
Study found glaucoma to be more prevalent among persons with older-
onset diabetes than in those without diabetes (4.2% versus 2%) (Klein et 
al., 1994). Similarly diabetic patients are at significantly increased risk of 
developing POAG (Bonovas et al., 2004). Of those persons with 
glaucoma, 13% had diabetes compared with 6.9% without glaucoma 
(Wilson and Martone, 1996). These authors hypothesized that small-
vessel disease or systemic blood abnormalities can result in compromised 
vascular perfusion to the optic nerve, which increases the risk of GON.  
It should be noted that persons with diabetes are more likely to be 
referred for or to seek an eye examination because of the risk of diabetic 
retinopathy. This might result in a clinical bias towards the detection of 
glaucoma among persons with diabetes in the general clinic population 
(Dignam and Stutman, 2001).  
A recent study assumed that DM is a protective against 
glaucomatous damage (Gordon et al., 2002). However, The authors 
explained this contradicting results by none confirming the diagnosis of 
DM in the participants neither by blood tests nor the used medication, 
moreover patients with diabetic retinopathy were excluded from the study 
which may explain the paradoxical relationship between the DM and 
POAG demonstrated in this study. 
 
16 
Review of literature 
 
3.4.5. Systemic blood pressure: 
Reports on the association between systemic hypertension (SHT) 
and POAG suggest that this association is more complex than previously 
assumed. Whereas some authors  found no positive association between 
SHT and POAG (Jonas and Grundler, 1998), others did (Tielsch et al., 
1995b; Wilson et al., 1987). Moreover, SHT seems to decrease the 
relative risk of POAG during 4 years of follow up (Leske et al., 2002). 
These findings are consistent with the hypothesis that SHT has a 
protective effect on early POAG development since it maintains an 
adequate perfusion pressure in the optic nerve (Grunwald et al., 1999). 
Some authors have considered SHT a weak risk factor for POAG, if it is 
risk factor at all. The possible role of atherosclerotic and ischemic 
vascular diseases, alone or in conjunction with SHT, is even less clear 
(Wilson and Martone, 1996). 
Low systemic blood pressure combined with high intraocular 
pressure was a stronger risk factor for glaucoma than was systemic 
hypertension per se. Antihypertensive treatment could induce hypotensive 
episodes, especially at night (Graham et al., 1995). 
Marked circadian fluctuation of the mean ocular perfusion pressure 
associated with nocturnal reduction in blood pressure beyond the 
physiological limit (20 ± 6 mmHg) (Choi et al., 2006) represents an 
additional risk for GON, particularly in normal-tension glaucoma (Fig. 4) 
(Graham et al., 1995; Kaiser and Flammer, 1991). 
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Fig. 4.  a) 24-hour blood pressure of a glaucoma patient :marked dip at the night(mmHg). 
            b) The lower the perfusion pressure, the more frequent glaucomatous damage arises. 
(reprinted from Flammer, 2006b, with permission from the publisher).  
a b
3.4.6. The appearance of the optic disc: 
The greater the tissue damage at the optic nerve head, the more 
likely a future progression of nerve fiber loss; but whether this is a 
genuine risk factor is still being debated. Theoretically, it seems possible 
that an already damaged disc could be more susceptible to increased IOP. 
Also if the patient has suffered from previous disc damage, chances are 
high for a further deterioration if the causes have not been eliminated 
(Flammer, 2006b).  
The relation of hemorrhages, at or near the optic disc, to GON is 
debatable. Some authors assume that the appearance of these 
hemorrhages points almost with certainty to a progression of existing 
damage (Siegner and Netland, 1996). In contrast, several authors have 
found no correlation between disc hemorrhage and disc changes or 
glaucomatous disk progression (Heijl, 1986; Tuulonen et al., 1987). 
 The size of an optic disc does not seem to be a risk factor. A given 
IOP will cause the same degree of damage, regardless of whether the 
optic disc is large or small (Flammer, 2006b) 
18 
Review of literature 
3.5. Choroidal hemodynamics 
3.5.1. General vasculature of the orbit and choroid (Fig. 5) 
 (most of this part has been quoted from the paper by Cioffi and 
Buskirk, 1995, with the permission from the publisher)  
The orbital contents receive their vascular supply from several 
arteries, including the ophthalmic artery, the meningolacrimal artery (a 
branch from the middle meningeal artery) and palpebral arteries which 
branch from the facial artery.  
The vascular supply to the intraorbital optic nerve, retina, and 
choroid arises predominantly from the ophthalmic arterial circulation 
via the posterior ciliary arteries, the central retinal artery, and the pial 
vascular network along the optic nerve. The ocular branches of the 
ophthalmic artery are the central retinal artery and one to five posterior 
ciliary arterial trunks. These trunks branch into the main posterior 
ciliary arteries. Most individuals have two to three posterior ciliary 
trunks which supply the medial and lateral posterior ciliary arteries. 
Each main posterior ciliary artery further divides into several short 
posterior ciliary arteries, just before or after entering the sclera. 
The short posterior ciliary arteries course anteriorly, and pierce 
the sclera immediately adjacent to the optic nerve, predominantly in the 
nasal and temporal region. They supply the posterior choroid, as well 
as the majority of the anterior optic nerve. Often the medial and lateral 
short posterior ciliary arteries anastomose and form an elliptical circle 
around the optic nerve, the arterial circle of Zinn and Haller. Branches 
derived from the circle of Zinn and Haller include recurrent pial 
branches, choroidal branches, and the branches penetrating the optic 
nerve.  
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The venous drainage of the orbit generally does not follow the 
arterial supply. The venous drainage of the retina and the anterior optic 
nerve is almost exclusively via the central retinal vein and its 
tributaries, which subsequently empty into the superior ophthalmic vein 
(the largest of the orbital veins). The choroid is drained through the 
vortex venous system, which empties into the superior and inferior 
ophthalmic veins. Both vessels drain into the cavernous sinus. 
However, the inferior ophthalmic vein occasionally drains into the 
pterygoid plexus through the inferior orbital tissue. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 Fig. 5. Ocular vascular supply (reprinted from Harris et al., 2003b, with permission 
from the publisher). 
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3.5.2. Regulation of choroidal blood flow (ChBF)  
 
Regulation of the blood in the choroidal vascular bed is achieved 
mainly through a mechanism involving either the autonomic nervous 
system (Alm, 1977; Alm and Bill, 1973) or the release of vascular 
endothelium related mediators (Haefliger et al., 1994a; Pournaras, 
1996). The former affects the contraction of the smooth muscle of 
choroidal arterioles, and the latter affects either the smooth muscle of the 
arterioles or the contractile state of pericytes surrounding the capillaries 
(Haefliger et al., 1994b). 
However, this regulatory mechanism can be disturbed in different 
pathological conditions such as diabetic retinopathy due to failure of the 
autonomic nervous system (Movaffaghy et al., 2002), and neovascular 
age related macular degeneration (ARMD) due to inability of the new 
vessels to increase their flow resistance during acute moderate elevation 
of  blood pressure (Pournaras et al., 2006). Herby, we can summarize the 
determinants of the choroidal circulation in the following manner: 
a. Autonomic nervous system 
Despite the fact that electrical stimulations of sympathetic and 
parasympathetic nerves have an influence on choroidal perfusion, the 
potential role of this phenomenon remains uncertain. It has been 
suggested that the extensive sympathetic innervation might protect the 
eye against overperfusion, during increased  perfusion pressure, by 
constriction of the choroidal blood vessels (Bill and Sperber, 1990). The 
dense vasodilative innervation of the choroid, on the other hand, might be 
important to increase ChBF under certain conditions, such as high light 
intensity (Parver et al., 1982). Although the presence of an active process 
of ChBF regulation in response to light exposure in humans has not been 
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confirmed, a reversible decrease in ChBF was demonstrated after a 
transition from room light to darkness, which could involve a neural 
mechanism (Longo et al., 2000). 
 
b. Vascular endothelium related mediators 
 
Vascular endothelial cells produce different vasodilating and 
vasoconstricting mediators such as, nitric oxide (NO), prostaglandins and 
endothelin-1, both under basal conditions and in response to many 
chemical and mechanical stimuli.  
NO is one of the most important endothelial relaxing factors. Many 
authors suggest that NO has a role in maintaining basal blood flow to 
choroid (Deussen et al., 1993; Luksch et al., 2003; Mann et al., 1995). In 
addition, NO is also released in response to an increase in shear stress. 
Shear stress is proportional to the viscosity and the flow of blood and 
inversely proportional to the radius of a blood vessel. Therefore changes 
in one of these parameters will have an influence on NO release and thus 
on the degree of relaxation of retinal vascular smooth muscle cells 
(Delaey and Van De Voorde, 2000).  
The endothelium also releases prostaglandins. They seem to have a 
complex vasoregulatory influence on retinal and choroidal blood vessels, 
depending on their relative vasodilating or vasoconstricting influence 
(Delaey and Van De Voorde, 2000). They have been suggested to play a 
potential role during the physiological adaptation of the choroid to the 
hypercapnia  in which a prominent vasodilatation in the choroidal blood 
vessels with increased ChBF occur (Stiris et al., 1992). 
The most potent vasoconstrictor released by endothelial cells is 
endothelin-1. Administration of endothelin-1 significantly reduces POBF 
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at concentrations which do not affect systemic hemodynamics 
(Schmetterer et al., 1997). This indicates that choroidal circulation is 
particularly sensitive to local endothelin-1 concentration and suggests that 
endothelin-1 may participate in the regulation of ChBF (Fuchsjager-
Mayrl et al., 2003). 
c. Autoregulation 
Autoregulation can be defined as the ability of a vascular bed to 
keep blood flow constant despite changes perfusion pressure (Guyton et 
al., 1971). Numerous studies have failed to demonstrate autoregulation in 
the choroidal circulation (Alm and Bill, 1972; Friedman, 1970). More 
recent studies suggest that the choroid has some capabilities to maintain 
its blood flow despite changes in perfusion pressure (Lovasik et al., 2003; 
Riva et al., 1997c). The authors suggested a neural or passive 
hemodynamical process rather than a myogenic or metabolic 
compensatory mechanism. 
d. Circulating molecules 
Some circulating molecules and hormones, such as angiotensin II 
and the catecholamines, are believed to have an influence on choroidal 
circulation. Studies of the effect of these molecules on the choroidal 
circulation, however, have yielded controversial results. Some studies 
show evidence that angiotensin II contract retinal and choroidal blood 
vessels (Dollery et al., 1963), while other authors did not observe any 
effect of angiotensin II on ChBF (Fuchsjager-Mayrl et al., 2003). A 
similar uncertainty exists in relation to the influence of catecholamines on 
the ocular circulation (Alm, 1972; Malik et al., 1976). 
 
23 
Review of literature 
 
3.5.3. Choroidal blood flow in glaucoma 
Choroidal vascular insufficiency has been implicated as a factor 
for the pathogenesis of glaucoma. Watershed zones in the choroid have 
been hypothesized. These zones appear to have a lower vascular supply 
than other areas of the choroid and are presumably at higher risk for 
ischemia during elevated IOP (Hayreh and Walker, 1967). Preliminary 
findings of reduced choroidal filling in glaucoma patients as determined 
by fluorescein filling times were also reported (Duijm et al., 1997; Jung 
et al., 1983).  
It is widely recognized that POBF and ocular pulse amplitudes are 
lower in POAG patients than in normal subjects (Agarwal et al., 2003; 
Fuchsjager-Mayrl et al., 2004; Trew and Smith, 1991). Alterations of 
posterior ciliary artery circulation in glaucoma patients have been also 
recorded by many authors using color Doppler technique (Birinci et al., 
2002; Nicolela et al., 1996a; Rankin, 1999; Vecsei et al., 1998). 
However, very few reports have recorded the subfoveal ChBF in 
glaucoma patients (Emre et al., 2004; Grunwald et al., 1998b). 
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3.6. Laser Doppler flowmetry (LDF) 
3.6.1. History   
The first measurements of blood flow velocity in capillary beds 
and in retinal artery using a laser Doppler technique were published in 
1972 (Riva et al., 1972). In a different application, these authors used 
LDF for measurements of the blood flow in the microcirculation of the 
optic nerve head (Riva et al., 1989). The widely recognized importance of 
understanding the pathophysiology of diseases such as diabetic 
retinopathy, ARMD and others, has recently led to the development of a 
new technique for the non-invasive measurement of ChBF. The 
feasibility of near-infrared (811 nm) LDF to quantify the subfoveal ChBF 
response to physiological stimuli has opened new avenues in the 
investigation of the physiology of the choroidal circulatory system (Riva 
et al., 1994).  
 
3.6.2. Optical Doppler effect  
LDF is based on the Doppler effect: laser light scattered by moving 
particle is shifted in frequency by an amount: Δf= V ( cos αs – cos αi ) n/λ 
where V is the velocity vector of the particle, αi and αs are the angles of 
the incident and the scattered light respectively, n is the index of 
refraction of the medium containing the particles and λ is the wavelength 
of the laser light (Fig. 6). When a laser beam illuminates RBCs moving in 
a net of capillaries with various velocities and directions, the light 
scattered by the RBCs and reaching the detector consists of a summation 
of waves with various Doppler shifts  (Petrig and Riva, 1999) (Fig. 7). 
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Fig. 6. Doppler effect of RBC moving at velocity V. Compared to the frequency (fi) 
of the light incident from the direction αi , the frequency of the light scattered in the 
direction αs is shifted by an amount Δf (reprinted from Riva, 2001, with permission 
from the publisher). 
Fig. 7.  Schematic diagram shows laser light impinging in a tissue and leaving it 
in the direction of the detector, after having been scattered by static tissue 
structures (small dots) and RBCs moving in blood vessels (large dots). 
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3.6.3. Blood flow parameters of subfoveal choroidal LDF 
The following flow parameters are obtained from the LDF of the 
subfoveal region of human ocular fundus: 
• Subfoveal choroidal blood velocity (ChBVel) = the mean velocity 
of the RBCs within the volume sampled by the laser light, which is 
proportional to the mean Doppler frequency shift. 
• Subfoveal choroidal blood volume (ChBVol) = Number of moving 
RBCs in the sampling volume. 
• Subfoveal choroidal blood flow (ChBF) = the flux of RBCs in the 
volume sampled by the laser. ChBF = Constant x ChBVel x ChBVol.  
ChBVel is expressed in Hz, while ChBVol and ChBF are 
expressed in arbitrary units. This means that LDF dose not provide 
absolute measurements of blood flow. It provides only relative blood 
flow measurements. The reasons are as follows. Laser radiation upon a 
tissue undergoes scattering, as well as absorption by the tissue and the 
RBCs. Both processes influence the penetration pattern of the laser light, 
which may differ from one region of a tissue to another, depending upon 
the spatial optical properties of the tissue. Thus, different tissue 
structures, as well as variations in this structure due to pathologies (for 
instance macular neo-vascularization) will affect the subfoveal ChBF 
measurements (Robinson et al., 1986). 
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3.6.4 Application of LDF on subfoveal region of human 
ocular fundus 
 
LDF measurement of choroidal blood flow in the foveal region of 
the human ocular fundus is a recent technology in which non-confocal 
(Riva et al., 1994) and confocal (Geiser et al., 1999) techniques have 
been used. The high spatial and temporal resolution of the LDF 
technique, particularly in the continuous mode, makes this technique 
most suitable for the investigation of the process of regulation of blood 
flow in response to various physiological stimuli. However, many other 
applications of choroidal LDF have been performed to study the effects 
of pathologic processes and various pharmacologic agents on the 
choroidal circulation. 
Many studies have been performed to demonstrate the alterations 
of the choroidal circulation in response to increases and decreases of 
perfusion pressure (Riva et al., 1997a; Riva et al., 1997b), valsalva 
maneuvers (Riva et al., 1994), dynamic exercise (Lovasik et al., 2003), 
breathing various gases, such as carbon monoxide (Resch et al., 2005). 
Investigations of various determinants of the ChBF regulation such as NO 
and endothelin 1  have been conducted using LDF (Fuchsjager-Mayrl et 
al., 2003; Longo et al., 2000; Luksch et al., 2003). 
Studies of the effect of aging, ARMD and choroidal 
neovascularization have been reported (Grunwald et al., 1998a; 
Grunwald et al., 1998b; Pournaras et al., 2006). Effects of pathological 
processes such as glaucoma (Grunwald et al., 1998b), diabetic 
retinopathy (Nagaoka et al., 2004; Schocket et al., 2004) and SHT 
(Metelitsina et al., 2006; Niknam et al., 2004) have also been 
demonstrated. Moreover, the pharmacological effects of some drugs, such 
as oral felodipine on ChBF  have been recorded (Schocket et al., 1999). 
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4. SUBJECTS AND METHODS 
 
The current study was carried out on selected subjects attending the 
outpatient clinics of Geneva Ophthalmology Center, Geneva University 
Hospitals, Switzerland, from February 2006 to December 2006. 
 
4.1. Subjects inclusion criteria: 
The subjects attending the outpatient clinics were divided into 3 
main groups: 
Group I. Subjects with POAG or with OHT: 
This group was further subdivided into 3 subgroups according to 
the guidelines of the European Glaucoma Society (European Glaucoma 
Society, 2003):  
a) Normal Tension Glaucoma (NTG) 
The diagnosis of NTG is based on the presence of typical 
glaucomatous optic nerve head changes, visual field defect typical of 
glaucoma with open anterior chamber angle and IOP < 22 mmHg without 
treatment (diurnal tension curve). 
 
b) High Tension Glaucoma (HTG) 
They included patients with POAG exhibiting acquired 
characteristic glaucomatous optic nerve damage and/or retinal nerve fiber 
layer changes (localized or diffuse). Visual field defect corresponding to 
optic nerve damage is usually detected and confirmed in at least two 
visual field examinations. All patients have open anterior chamber angle 
and IOP > 21 mmHg without treatment (diurnal tension curve). 
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c) Ocular Hypertension (OHT) 
The diagnosis of the OHT is based on normal optic disc 
appearance, normal visual field and retinal nerve fiber layer, open 
anterior chamber angle and an IOP of 22 mmHg or greater without 
treatment (diurnal tension curve). 
 
 
NB 
1) Central corneal thickness (CCT) measurement was done in certain cases to 
correct for Goldmann applanation IOP measurement especially when the clinical 
finding did not match with the IOP level. An approximately 1 mm Hg correction for 
every 25 micron deviation from a CCT of 550 micron. The correction values were 
positive as thickness decreased and negative as thickness increased (Kohlhaas et al., 
2006). 
2) Most of patients with HTG were under glaucoma mediacation(s), while most 
of NTG and OHT patients were investigated before starting their therapy. 
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Group II. Subjects with glaucomatous risk factors: 
This group was further subdivided into 3 subgroups according to 
the glaucomatous risk factors:  
a) Subjects with diabetes mellitus (DM): They included subjects with 
history of DM or elevated fasting blood glucose ≥ 7.00 mmol/l 
(140%) (Mitchell and Wang, 1999). Patients with vitreous hemorrhage or 
advanced retinal problems (such as retinal detachment) were excluded. 
The severity of diabetic retinopathy was defined according to the 
modified Airlie House system used in the Early Treatment Diabetic 
Retinopathy Study (ETDRS, 1991).  
These subjects were further subdivided into 2 subgroups: 
i)  Patients without POAG and with normal IOP (<22 mm Hg). 
ii)  Patients with POAG.  
b) Subjects with systemic hypertension (SHT):  SHT was considered as 
consistently having increased blood pressure with current use of 
antihypertensive medication or elevated blood pressure (systolic ≥ 160 or 
diastolic ≥ 95mmHg) (De Lena de Ruotolo et al., 1992). All hypertensive 
patients included in the current study were under antihypertensive 
thereby. As in diabetic group, they were subdivided into 2 subgroups 
(without and with POAG). 
 
c) Subjects with myopia: In the present study, we defined moderate  
myopia as myopia with spherical equivalent between -3 and -8 diopters, 
and high myopia as myopia with spherical equivalent greater than -8 
diopters (Shimada et al., 2004). Patients with moderate and high myopia 
were included (Mitchell et al., 1999). To exclude the influence of myopic 
retinopathy, highly myopic eyes with myopic chorioretinal atrophy were 
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excluded from the study (Avila et al., 1984). Similarly to subjects with 
DM, myopic subjects were subdivided into 2 subgroups (without and 
with POAG). 
Group III. Control subjects: 
They fulfilled the following criteria: 
 IOP < 22mm Hg. 
 No significant error of refraction (±3 diopters). 
 Normal optic disc clinical findings. 
 Normal visual field.  
 No past history or family history of glaucoma. 
 No history of any ocular or systemic disease 
 No ocular or systemic medication. 
 Neither smokers nor alcoholics. 
4.2. Subjects exclusion criteria: 
Subjects fulfilling one or more of following criteria were 
excluded from the study:  
• Other types of glaucoma such as: angle closure or secondary glaucoma. 
• Concomitant ocular disease such as uveitis or retinal detachment. 
• Any ocular disease that can prevent fair visualization of the posterior 
segment or interfere with accurate applanation tonometry. 
• Ocular disease, other than POAG, potentially associated with optic 
neuropathy, such as anterior ischemic optic neuropathy or congenital 
optic nerve anomaly. 
• Neurological disorders or retinal diseases affecting the visual field. 
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• History of intra-ocular surgery or ocular injury. 
• All systemic diseases except DM or SHT. 
• All patients who are smokers and /or alcohol drinkers. 
• Mixed criteria (e.g. diabetic patients having either hypertension or 
high myopia). 
• Patients with any ocular medication except anti glaucoma thereby. 
• Patients with systemic medication except for SHT or DM. 
 
4.3. Baseline examination: 
The clinical characteristics of the subjects included in this study 
were based upon the data obtained from history taking and ocular 
examination. 
4.3.1. History taking: 
•   Personal history 
• Complaint and present history 
• Past history: A careful history for previous ocular diseases rather than 
POAG, ocular trauma, or treatment (either medical, surgical or 
LASER treatment). 
• General medical history included: a) cardiovascular diseases such as  
hypertension, hypotension, peripheral vascular diseases, and coronary 
artery disease, b) endocrinal disorders such as diabetes mellitus and 
thyroid diseases, c) collagen diseases, d) blood diseases, e) autoimmune 
diseases, f) systemic medications such as anti hypertensive drugs, 
hormonal replacement therapies or corticosteroids. 
• Family history of glaucoma  
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4.3.2. Ophthalmological examination: 
• Visual acuity: Assessment of visual acuity (unaided and aided) was 
performed using projector chart with decimal notation. 
• Refraction: Determination of refraction was achieved using Nidek 
ARK-700A followed by assessment of best corrected visual acuity. 
• Tonometry: The IOP was measured by Goldmann applanation 
tonometer mounted on a slit-lamp. 
• Slit-lamp examination: The anterior segment of the eye was 
carefully examined to exclude causes of secondary glaucoma. 
• Gonioscopy: The anterior chamber angle was examined with the aid 
of a Goldmann three-mirror contact lens and slit-lamp biomicroscopy. 
The angle was graded at gonioscopy according to Shaffer grading 
system (Shaffer, 1960). Angle with grade 3 and 4 are considered open. 
• Fundus examination: The fundus was examined by direct 
ophthalmoscopy and with Goldman 3- mirror contact lens to assess 
optic disc changes in glaucoma and to exclude macular lesions, 
vascular lesions, optic nerve anomalies, and other lesions that may 
produce visual field defects. 
NB 
We were masked during the investigation of myopic, hypertensive and control 
groups as most of them were collected from the emergency unit or the general 
outpatient clinics without knowing their exact diagnosis. On the other hand, to study a 
significant numbers of diabetic and glaucoma patients, they should be collected from 
the diabetic and glaucoma outpatient clinics respectively. However, detailed clinical 
data of the patients (e.g. grade of retinopathy, IOP, visual field) were hidden till 
achievements of the measurements. 
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4.4. Laser Doppler Flowmetry (LDF) 
4.4.1. Procedure of LDF measurements of the subfoveal 
choroidal blood flow  
All patients participating in the study were given a detailed 
explanation of the procedures. An appropriate consent form, approved by 
the institution, was obtained. The study was approved by the Ethical 
Committee of the Medical Faculty of the University of Geneva and 
followed the tenets of the Declaration of Helsinki. 
Measurements of choroidal hemodynamic were conducted on one 
randomized chosen eye of each subject using a Topcon based fundus 
camera Lased Doppler flowmetry system (LDF) (Fig. 8). 
A probing laser beam (wavelength = 810 nm, power at the cornea = 
60 μW) was directed to the fundus through the illumination pathway of 
the fundus camera. The optical fiber aperture, used to detect the scattered 
light, was placed at the center of the illuminated site (nominal diameter 
450 μm, imaged to approximately 150 μm at the fundus) (Fig. 9). 
 Subjects were asked to fixate on the probing laser beam while 
proper fixation was confirmed by direct visualization of the foveola 
through the monitor of a television camera sensitive to near infrared light. 
During all measurements, the Doppler signal was fed into a loudspeaker, 
allowing the pulsating pitch of the signal to be heard. 
The collected laser light was guided on a photodetector, whose 
output signal was analyzed by a NeXT computer (NeXT Computer, Inc, 
Redwood City, California) with software (NeXT Software, Inc, Redwood 
City) specifically developed for the analysis of Doppler signals from 
ocular tissue to obtain relative measures of ChBVel, ChBVol and ChBF  
(see definitions in page 27). Measurements obtained in this fashion, from 
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the centre of the foveola, correspond mainly to blood flow in the 
choriocapillaries (Riva et al., 1994) (Fig. 10). 
The portion of the Doppler shift power spectrum between 32 and 
2500 Hz was used for the determination of the flow parameters. The 
region between 2500 and 5000 Hz served to determine the shot noise 
level, which was subtracted from the spectrum before calculating the flow 
parameters. The direct currency (DC) of the Doppler signal, which is 
proportional to the total amount of light reaching the detector was also 
recorded and used to monitor the position of the camera and to remove 
the portions of recordings associated with blinks. Spikes occurring mainly 
in ChBVol and lasting less than 0.1 sec were attributed to micro-saccadic 
eye motion and were also removed from the recording. 
Five separate (20–30 seconds) measurements of the choroidal 
circulation were obtained. Only stable portions of the measurements were 
included. Analyses of the data from the five separate recordings were 
averaged. 
Upon completion of LDF measurements, brachial artery systolic 
(BPs) and diastolic blood pressure (BPd) were obtained by 
sphygmomanometer. Mean brachial blood pressure (BPm) was calculated 
using the following standard formula:   BPm =  BPd + 1/3 (BPs-BPd). 
The mean ophthalmic arterial pressure (MOAP) was assumed to be 2/3 of 
the (BPm). The mean perfusion pressure (PP) was calculated according 
to the formula:  PP = MOAP –IOP. The mean vascular resistance (R) 
was defined as: R = PP/ChBF (Riva et al., 1986). 
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Fig. 9.  a: The site of applied laser beam of LDF in the foveal region in the fundus. 
            b: A photodetector collects scattered light from a 150um circular area of the 
fundus surrounding the laser spot.  
(reprinted from Harris et al., 2003a, with permission from the publisher). 
a b 
Fig. 8. Lased Doppler Flowmetry system (Geneva Ophthalmology Clinic) 
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Fig. 10. A cross-section of the fundus at the fovea, where the retina has the best 
viewing resolution, shows: first the retinal vascular bed which lies above the retina, 
then a layer of photoreceptors and behind the choroid. At the fovea, there are no 
retinal vessels, so that when we illuminate this zone with the probe laser, RBCs from 
the retina will be illuminated and the entire signal that we will detect arises from the 
choroid (Courtesy from Prof. Charles Riva). 
4.4.2. Typical LDF recordings of the subfoveal region of a 
normal volunteer 
 
 
 
 
 
 
 
Fig. 11. ChBVel, ChBVol and ChBF obtained from the subfoveal region of a 
normal volunteer. The changes in these hemodynamical parameters during 2 heart 
cycles are shown at the right. They were derived from a 20 sec recording segment 
(shaded area) using the pulse pressure wave from the ear to average all data with 
the same phase of the cardiac cycle and repeating this operation for all phases. 
     
ChBVel 
    ChBF 
ChBVol 
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4.5. Statistical Analysis 
Data were analyzed using SPSS program (Standard version 10, 1999).  
• Quantitative data were presented in the form of mean and standard 
deviation (mean ± SD). 
• A one-way analysis of variance (ANOVA) across the different 
groups was carried out for each set of variables followed where 
appropriate by a pos hoc t test using the Bonferroni correction. 
• The chi-square test was used for categorical data.  
• Pearson’s correlation was used for the correlations of different 
parameters that were assumed to have a normal distribution. 
• Multiple regression analysis was carried out to examine the relation 
between the choroidal circulatory parameters as the dependent 
variables and certain predictor variables in normal or glaucomatous 
patients such as IOP and PP. 
• Scatterplot graphs were performed by Microsoft Excel set for data 
analysis, showing the linear correlation between two variables. 
• Two independent sample test (Mann-Whitney U) was used to 
compare the circulatory parameters of the two different groups (e.g. 
types I and II D.M.) 
• Statistical significance was set at p ≤ 0.05. 
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5. RESULTS 
5.1. Demographic data of the studied subjects 
This study included 389 subjects (190 males and 199 females) 
collected from outpatient clinics of Geneva Ophthalmology Center. They 
aged from 14 to 90 years. The best corrected visual acuity ranged from 
0.1 to 1.00 and refraction ranged from +3 to -13 diopters. They had an 
IOP from 10 to 28 mmHg. The Demographic data of the investigated 
subjects are demonstrated in Table 2.  
Table 2. Demographic data of the all studied groups (mean±SD) 
Subjects with glaucomatous risk factors 
POAG 
DM SHT Myopia Character 
NTG HTG OHT i ii i ii i ii 
Control  P Value 
No. 
Patients 34 51 25 68 25 27 30 17 12 100  
Age(Years) 56 ±15 
60 
±15 
62 
±21 
60 
±14 
65 
±13 
63 
±14 
61 
±14 
60 
±10 
61 
±21 
57 
±16 NS 
Sex:   M 16 
18 
28 
23 
11 
14 
36 
32 
13 
12 
12 
15 
14 
16 
9 
8 
6 
6 
47 
53 NS*            F 
IOP  18 
(mm Hg) ±4 
17 
±2 
23 
±4 
14 
±2 
16 
±2 
14 
±2 
17 
±3 
14 
±2 
16 
±2 
14 
±2 <0.05
 a
Ref. 0.7 
(Diopters) ±1.3 
0.6 
±1.5 
0.8 
±1.3 
0.5 
±0.9 
0.8 
±1.4 
0.8 
±1.1 
0.8 
±1.6 
-5.6 
±2.7 
-5.0 
±1.0 
0.2 
±1.1 <0.01
 b
UCVA 0.7 ±0.2 
0.9 
±0.2 
0.8 
±0.2 
0.7 
±0.2 
0.7 
±0.3 
0.8 
±0.2 
0.7 
±0.2 
0.3 
±0.2 
0.3 
±0.1 
0.9 
±0.1 <0.01
 c
BCVA 0.9 ±0.2 
1.0 
±0.1 
0.9 
±0.1 
0.8 
±0.2 
0.8 
±0.2 
0.9 
±0.2 
0.9 
±0.2 
0.8 
±0.1 
0.8 
±0.2 
1.0 
±0.1 NS 
BPs 
(mmHg) 
128   
±8 
138 
±10 
136 
±7 
137 
±10 
139 
±8 
134 
±6 
138 
±9 
131 
±5 
136 
±8 
129 
±11 NS 
BPd 84 
±6 
82 
±7 
87 
±6 
84 
±7 
85 
±6 
83 
±7 
86 
±6 
81 
±7 
85 
±7 
80 
±8 NS (mmHg) 
PP 51 
(mmHg) ±7 
49 
±6 
49 
±6 
54 
±5 
53 
±5 
52 
±4 
52 
±5 
51 
±3 
52 
±5 
51 
±5 NS 
i= without POAG    ii = with POAG No.=number   M=Male   F=Female IOP = Intra ocular pressure 
Ref. = Refraction (spherical equivalent) UCVA= un corrected visual acuity BCVA = best corrected visual acuity 
BPs =Systolic blood pressure BPd =Diastolic blood pressure PP = Perfusion pressure  
NS =Non significant at level of  0.05 * Chi square test P : significant  at ≤ 0.05 (ANOVA) 
a (Significant difference between OHT group and the other groups     
b, c (Significant difference between myopia group and other groups)    
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5.2. Baseline LDF data of all studied groups 
Table 3 summarizes the baseline choroidal LDF data of the all 
studied groups. One way ANOVA test reveals statistically significant 
difference among the studied groups. ChBVel, ChBVol and ChBF were 
significantly decreased and the R was increased in all patients groups 
compared to the age matched control group. Distribution of the ChBF in 
the different studied groups is illustrated in Fig. 12. It is important to 
emphasis that the direct currency (DC) of the Doppler signal is not 
significantly different among the different population indication that the 
measurements were similarly adjusted in the different studied groups and 
not affected by other factors e.g. media opacity as in the case of incipient 
cataract (Fig. 13). Figure 14 demonstrates the distribution of the LDF 
parameters among the normal population. 
  
Table 3. Baseline LDF data of all studied groups and subgroups (mean±SD) 
Subjects with glaucomatous risk factors 
POAG 
DM SHT Myopia Character 
NTG HTG OHT i ii i ii i ii 
Control  P Value 
No. 
Patients 34 51 25 68 25 27 30 17 12 100 - 
ChBVel 
(kHz) 
1.3 
± 0.4 
1.3 
± 0.4 
1.3  
± 0.3 
1.1  
± 0.5 
1.2 
 ±0.5 
1.2  
± 0.4 
1.2  
± 0.5 
1.2  
± 0.3 
1.3  
± 0.4 
1.5  
± 0.4 <0.05 
ChBVol 
(a.u) 
0.14
± 0.1 
0.14 
± 0.1 
0.13 
± 0.1 
0.12 
± 0.1 
0.11  
± 0.1 
0.18  
± 0.3 
0.16 
± 0.1 
0.11 
± 0.1 
0.08  
± 0.0 
0.27 
 ± 0.1 <0.01 
ChBF 
(a.u) 
4 ± 1 4 ± 2 3 ± 1 3 ± 1 3 ± 1 3 ± 1 3 ± 1 2 ± 1 2 ± 1 8 ± 2 <0.01 
DC 2.7  ± 0.7 
2.6  2.6  2.8  2.8  2.9 2.8  2.9  2.9  2.8  
± 0..6 NS ± 0.8 ± 0.8 ± 0.6 ± 0.7  ± 0.6 ± 0.8 ± 0.7 ± 0.5 
R 
(a.u) 
16  
± 8 
16  
± 7 
15  
± 6 
23  
± 12 
22  
± 9 
18  
± 7 
26  
± 14 
24 
 ± 9 
26  
± 9 
7  
± 2 <0.01 
i= without POAG     ii = with POAG P : significant  at ≤ 0.05 (ANOVA) 
ChBVel = Choroidal blood velocity R = Mean vascular resistance 
ChBVol = Choroidal blood volume a.u= arbitrary units 
DC = Direct Currency ChBF = Choroidal blood flow 
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Fig. 13. Distribution of the DC in the different studied groups. 
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Fig. 12. Distribution of the ChBF (a.u) in the different studied groups. 
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5.3. Correlations between each of the LDF parameters and 
clinical variables of the subjects 
 
5.3.1 Correlations between each of the LDF parameters and age, IOP 
and PP respectively in normal population. 
 
Table 4 reveals significant correlation between the PP and the R. 
However, no other significant correlations between each of the choroidal 
LDF parameters and any of the studied variables were demonstrated. 
Figures 15 and 16 demonstrate scatter plot association between ChBF and 
the age and PP respectively. No significant association was noted 
between the studied variables. 
 
 
Table 4. Multiple regression analysis showing correlations between each of the LDF 
parameters and age, IOP and PP respectively in normal population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGE (Years) IOP (mmHg) PP (mmHg) LDF 
parameter t p t p t p 
NS ChBVel (kHz) 0.48 NS 0.26 NS 0.43 
ChBVol (a.u) 0.36 NS 0.14 NS 0.45 NS 
ChBF (a.u) 0.24 NS 1.00 NS 0.04 NS 
R (a.u) 0.33 NS 0.69 NS 0.01 2.56 
Correlation is Significant at p ≤ 0.05   NS = Non significant 
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Fig. 15. Linear correlation between the 
ChBF and the age in the control group.  
 (r = 0.098, p=0.33) 
 
Fig. 16. Linear correlation between the 
ChBF and the PP in the control group.  
 (r = 0.049, p=0.63) 
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5.3.2. Correlations between each of the LDF parameters and IOP, PP 
and C/D respectively in POAG and OHT patients 
 
Multiple regression analysis was used also to examine the relation 
between each of LDF parameters as the dependent variables and IOP, PP 
and C/D respectively as predictor variables in patients with POAG or 
OHT. Table 5 and 6 reveal no significant correlation among the studied 
variables in either group. 
 
Table 5. Multiple regression analysis showing correlations between each of the LDF 
parameters and IOP, PP and C/D respectively in POAG patients. 
IOP (mmHg) PP (mmHg) C/D LDF 
parameter t p t p t p 
NS ChBVel (kHz) 1.15 NS 1.37 0.38 NS 
ChBVol (a.u) 0.24 NS 0.16 NS 0.18 NS 
ChBF (a.u) 0.87 NS 0.15 NS 0.98 NS 
R (a.u) 0.62 NS 1.25 NS 0.81 NS 
Correlation is Significant at p ≤ 0.05    NS = Non significant 
 
 
 
Table 6. Multiple regression analysis showing correlations between each of the LDF 
parameters and IOP, PP and C/D respectively in OHT patients. 
IOP (mmHg) PP (mmHg) C/D LDF 
parameter t p t p t p 
ChBVel (kHz) 0.11 NS 1.20 NS 1.24 NS 
ChBVol (a.u) 1.97 NS 1.33 NS 1.01 NS 
ChBF (a.u) 1.67 NS 0.94 NS 0.04 NS 
R (a.u) 1.76 NS 1.67 NS 0.33 NS 
Correlation is Significant at p ≤ 0.05    NS = Non significant 
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5.4. Analysis of LDF data of POAG and OHT groups 
All the measured circulatory parameters (ChBVel, ChBVol, and 
ChBF) were significantly reduced and the R was increased in the patients 
with NTG, HTG or OHT, in comparison to age matched controls, while 
there was no statistically significant difference among the three groups 
using post hoc Bonferroni test for multiple comparisons (Table 7). 
Descriptive analysis of the studied groups is demonstrated in box blot 
graph (Fig. 17). 
Table 7. LDF parameters (mean±SD) in control group, NTG , HTG and OHT patients 
(One way ANOVA analysis) 
Control NTG HTG  OHT LDF ANOVA Post hoc 
 
 
 
 
 
Parameter (1) (n=100 ) 
 (2) 
(n=34 ) 
(3)  (4) 
(n=51 ) (n=25 ) 
(P value) test* 
ChBVel (kHz) < 0.05 1.5 ± 0.4 1.3 ± 0.4 1.3 ± 0.4 1.3 ± 0.3 1-2,1-3,1-4 
ChBVol (a.u) <0.01 0.27 ± 0.1 0.14 ± 0.06 0.14 ± 0.1 0.13 ± 0.05 1-2,1-3,1-4 
ChBF (a.u) <0.01 8 ± 2 4 ± 1 4 ± 2 3 ± 1 1-2,1-3,1-4 
R (a.u) <0.01 7 ± 2 16 ± 8 16 ± 7 15 ± 6 1-2,1-3,1-4 
        *Bonferroni test for multiple comparisons  (P : significant  at ≤ 0.05)   a.u= arbitrary units  
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Fig. 17. Box plots 
show the median, 
interquartile range, 
outliers, and extreme 
cases of ChBF in 
control, NTG, HTG 
and OHT groups 
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5.5. Analysis of LDF data of diabetic patients 
 
The three choroidal circulatory parameters (ChBVel, ChBVol, and 
ChBF) and the R differed significantly among the three analyzed groups 
(diabetics without and with POAG and the controls) as revealed by one 
way ANOVA analysis (Table 8).  
Using the Bonferroni test for multiple comparisons, the diabetic 
patients showed statistically significant reduction of the all circulatory 
parameters with significant increase in the R in comparison to age 
matched controls. Meanwhile, there was no significant difference in any 
parameter between the two subgroups of diabetics (without and with 
POAG). To clarify the effect of DM as a risk factor in the glaucomatous 
patients, the analyzed data of the diabetic patients with glaucoma were 
compared with those of glaucoma without DM. Significant reduction of 
the ChBF and increased R were noted in the glaucoma group with DM 
(Table 9). 
 
Table 8. LDF parameters (mean±SD) in the control group, diabetic patients without 
POAG and diabetic patients with POAG (ANOVA test). 
LDF Control DM DM+POAG ANOVA 
Parameter (n=100 ) (n=68 ) (n=25 ) (P value) 
ChBVel (kHz) 1.5 ± 0.4 1.1 ± 0.5 1.2 ± 0.5 < 0.05 
ChBVol (a.u) 0.27 ± 0.10 0.12 ± 0.06 0.11 ± 0.07 <0.01 
ChBF (a.u) 8 ± 2 3 ± 1 3 ± 1 <0.01 
R (a.u) 7 ± 2 23 ± 12 22 ± 9 <0.01 
 Significance : at the level of  p ≤ 0.05 
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Table 9. LDF parameters (mean±SD) of the controls, diabetic patients (without and with 
POAG) and glaucoma patients (Bonferroni test for multiple comparisons). 
 
Table 10 shows the comparison of the LDF parameters among 
diabetic patients with different grades of retinopathy. There was a 
tendency of the circulatory parameters to decrease and the R to increase 
with more advanced diabetic grade. However, one way ANOVA analysis 
showed no statistically significant difference among the four subgroups 
Similarly, we did not find any significant difference in the 
measured parameters between patients with type I or type II DM (Table 
11). Moreover no significant correlation was detected between the 
duration of diabetes and the ChBF (Fig. 18). 
Table 10. Comparison of LDF parameters (mean±SD) among diabetic patients with 
different grades of retinopathy (ANOVA test). 
LDF 
Parameter 
G0 
(n=22 ) 
G1 
(n=17 ) 
G2 
(n=14 ) 
G3 
(n=15 ) 
ANOVA 
(P value) 
ChBVel (kHz) 1.1 ± 0.8 1.2 ± 0.2 1.2 ± 0.5 1.0 ± 0.2 NS 
ChBVol (a.u) 0.12 ± 0.06 0.12 ± 0.06 0.11 ± 0.05 0.09 ± 0.03 NS 
ChBF (a.u) 3 ± 1.2 3 ± 1.1 3 ± 1.2 3 ± 0.8 NS 
R (a.u) 22 ± 10 23 ± 7 23 ±11 25 ± 12 NS 
G0=Non diabetic retinopathy G1=Mild/Moderate non proliferative diabetic retinopathy 
G2=Severe non proliferative diabetic retinopathy G3= Proliferate diabetic retinopathy 
NS = Non significant  
LDF 
Parameter 
Control 
(n=100 ) p 
DM 
(n=68 ) 
DM+ POAG p POAG p (n=51) (n=25 ) 
ChBVel 
(kHz) 1.5 ± 0.4 1.1 ± 0.5 NS 1.2 ± 0.5 NS 1.3 ± 0.4 < 0.05 
ChBVol 
(a.u) 0.27 ± 0.1 0.12 ± 0.06 NS 0.11 ± 0.07 NS 0.14 ± 0.06 <0.01 
ChBF 8 ± 2 3 ± 1 NS 3 ± 1 4 ± 2 <0.01 < 0.05 (a.u) 
R(a.u) 7 ± 2 23 ± 12 NS 22 ± 9 16 ± 7 <0.01 <0.01 
Significance : at the level of  p ≤ 0.05 NS = Non Significant at the level of 0.05 
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Table 11. Comparison of LDF parameters (mean±SD) between patient with type I and 
type II DM. 
LDF Parameter TYPE I TYPE II P value* (n=20 ) (n=48 ) 
NS ChBVel (kHz) 1.1 ± 0.2 1.2 ± 0.6 
NS ChBVol (a.u) 0.11 ± 0.03 0.12 ± 0.06 
NS ChBF (a.u) 2.9 ± 0.7 3 ± 1.2 
NS R (a.u) 23 ± 7 22 ± 10 
* Unpaired t test, significance at p ≤ 0.05 NS = Non significant.  
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Fig. 18. Linear correlation between the duration of DM and the ChBF in diabetic 
patients (r = - 0.9, p=0.52). 
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5.6. Analysis of LDF data of hypertensive patients 
 
 
Our results demonstrated significant differences of the LDF 
parameters between the hypertensive patients and age matched controls 
(Table 12). Using Bonferroni test, we noticed that the all measured LDF 
parameters were significantly reduced and the R was increased in the 
patients with SHT compared to age matched controls, while there was no 
statistically significant difference between hypertensive patients without 
and with POAG except in the R which was significantly increased in 
hypertensive patients with glaucoma. We also noticed significant 
reduction in the ChBF and increased R in glaucomatous patients with 
SHT compared to glaucomatous patients without SHT (Table 13). 
Table 12. LDF parameters (mean±SD) in the control group, SHT patients without POAG 
and SHT patients with POAG (ANOVA test). 
 
Table 13. LDF parameters (mean±SD) of the controls, SHT group (without and with 
POAG) and POAG group (Bonferroni test for multiple comparisons). 
LDF 
Parameter 
Control 
(n=100 ) p 
SHT 
(n=27 ) p 
SHT 
+POAG 
(n=30 ) 
p POAG (n=51) 
ChBVel 
(kHz) 1.5 ± 0.4 <0.05 1.2 ± 0.4 NS 1.2 ± 0.5 NS 1.3 ± 0.4 
ChBVol 
(a.u) 
0.27 ± 
0.1 <0.01 0.18 ± 0.3 NS 0.16 ± 0.08 NS 0.14 ± 0.06 
ChBF 
(a.u) 8 ± 2 <0.01 3 ± 1 NS 3 ± 1 <0.05 4 ± 2 
R(a.u) 7 ± 2 <0.01 18 ± 7 < 0.05 26 ± 14 <0.01 16 ± 7 
NS = Non Significant. Significance : at the level of  p ≤ 0.05 
LDF 
Parameter 
Control 
(n=100 ) 
SHT SHT ANOVA +POAG (n=27 ) (P value) (n=30 ) 
ChBVel (kHz) 1.5 ± 0.4 1.2 ± 0.4 1.2 ± 0.5 < 0.05 
ChBVol (a.u) 0.27 ± 0.10 0.18 ± 0.34 0.16 ± 0.08 <0.01 
ChBF (a.u) 8 ± 2 3 ± 1 3 ± 1 <0.01 
R (a.u) 7 ± 2 18 ± 7 26 ± 14 <0.01 
 Significance : at the level of  p ≤ 0.05 
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5.7. Analysis of LDF data of myopic subjects 
 
One way ANOVA test revealed a significant difference in the 
measured choroidal LDF parameters among the myopic subjects (without 
and with POAG) and the age matched controls (Table 14). 
With Bonferroni test, the myopic eyes revealed significantly 
reduced LDF parameters and increased R in comparison to age matched 
controls. Theses parameters did not differ significantly between myopic 
subjects without and with POAG. Compared to emmetropic 
glaucomatous patients, significant reduction of the ChBVol and ChBF 
and increased R were recorded in glaucomatous myopic patients       
(Table 15).  
Table 14. LDF parameters (mean±SD) in the control group, myopic subjects without POAG 
and myopic subjects with POAG (ANOVA test). 
 
Table 15. LDF parameters (mean±SD) of the controls, myopic subjects (without and with 
POAG) and POAG group (Bonferroni test for multiple comparisons). 
LDF 
Parameter 
Control 
(n=100 ) p 
Myopia 
(n=17 ) p 
Myopia 
+POAG 
(n=12 ) 
p POAG (n=51) 
ChBVel 
(kHz) 1.5 ± 0.4 < 0.05 1.2 ± 0.3 NS 1.3 ± 0.4 NS 1.3 ± 0.4 
ChBVol 
(a.u) 0.27 ± 0.1 <0.01 0.11 ± 0.08 NS 0.08 ± 0.04 < 0.05 0.14 ± 0.06 
ChBF  
(a.u) 8 ± 2 <0.01 2 ± 1 NS 2 ± 0.7 < 0.05 4 ± 2 
R(a.u) 7 ± 2 <0.01 24 ± 9 NS 26 ± 9 <0.05 16 ± 7 
NS = Non Significant. Significance : at the level of  p ≤ 0.05 
LDF 
Parameter 
Control 
(n=100 ) 
Myopia Myopia ANOVA +POAG (P value) (n=17 ) 
(n=12 ) 
ChBVel (kHz) 1.5 ± 0.4 1.2 ± 0.3 1.3 ± 0.4 < 0.05 
ChBVol (a.u) 0.27 ± 0.10 0.11 ± 0.08 0.08 ± 0.04 <0.01 
ChBF (a.u) 8 ± 2 2 ± 1 2 ± 0.7 <0.01 
R (a.u) 7 ± 2 24 ± 9 26 ± 9 <0.01 
 Significance : at the level of  p ≤ 0.05 
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5.8. Comparison of baseline LDF data of groups with various 
glaucoma risk factors. 
Comparing the effect of various risk factors (HTG, DM, SHT and 
myopia) on the choroidal hemodynamics using one way ANOVA 
analysis revealed significant difference in the ChBF and the R among the 
four groups (Fig. 19). The reduction in the ChBF and the increased R are 
most marked in diabetic and myopic patients when compared with the 
glaucomatous group. On the other hand there was no significant 
difference among the different groups as regard the ChBVel and ChBVol 
(Table 16). 
Table 16. Comparison of baseline LDF data (mean±SD) of groups with various glaucoma 
risk factors (HTG, DM, SHT and myopia). 
 
 
LDF 
Parameter 
 
HTG 
(1) 
(n=51 ) 
 
DM 
(2) 
(n=68 ) 
  
Post hoc SHT Myopia ANOVA 
(3) 
(n=27 ) 
(4) Test* (P value) 
(n=17) 
ChBVel 
(kHz) NS - 1.3 ± 0.4 1.1 ± 0.5 1.2 ± 0.4 1.2 ± 0.3 
ChBVol NS - 0.14 ± 0.1 0.12 ± 0.1 0.18 ± 0.3 0.11 ± 0.1 (a.u) 
ChBF <0.01 1-2,1-4 3.8 ± 2.4 2.8 ± 1.1 3.3 ± 1 2.3 ± 1 (a.u) 
R <0.01 1-2,1-4 16 ± 7 23 ± 12 18 ± 7 24 ± 9 (a.u) 
 *(Bonferroni t test for multiple comparisons) NS = Non Significant at the level of 0.05 
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Fig. 19. ChBF (a.u) in HTG, DM, SHT and myopia groups (data are presented as mean ± 
SD). There is significant decrease of the ChBF in the diabetic and myopic groups in 
comparison with the HTG group (p<0.01). 
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6. DISCUSSION 
 
The role of vascular factors in the pathogenesis of glaucoma 
continues to be an active area of research. The identification of 
circulatory disorders, vascular risk factors and compromised blood flow 
in glaucoma patients firmly link impaired ocular perfusion to 
glaucomatous damage. The development of new techniques such as LDF 
to evaluate the ocular circulation has greatly improved our ability to 
obtain high quality measurements of ocular blood flow.  
In this clinical study, different groups of glaucoma patients were 
investigated by LDF to measure the choroidal circulation and to correlate 
the obtained parameters with a number of glaucoma predictor variables 
such as IOP and PP. Moreover, this study assessed the angiopathic effect 
of glaucoma risk factors (DM, SHT and myopia) on choroidal circulation 
and subsequently their role in GON. 
6.1. Correlations between each of LDF parameters and 
age and PP, respectively, in the normal population 
6.1.1. Age  
Our data revealed that there is no significant correlation between 
ChBF and the age (Fig. 15, page 44). These results are in agreement of 
other studies demonstrating that the age has no effect on ChBF 
(Pournaras et al., 2006; Riva et al., 1994; Schocket et al., 2004). 
However, the results of the current study do not agree with many authors 
revealing a negative correlation between the age and ChBF using 
different techniques such as POBF measurement (Dallinger et al., 1998; 
Lam et al., 2003; Ravalico et al., 1996) and LDF (Grunwald et al., 
1998a; Niknam et al., 2004; Straubhaar et al., 2000).  
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6.1.2. PP 
With regard to the PP, our findings demonstrated that there is no 
significant correlation between the PP and ChBF in normal population  
(Fig. 16, page 44). These findings support that the choroidal circulation 
has a regulatory capacity that maintain constant ChBF in spite of some 
changes in the PP. This maintenance may be achieved through an 
increase in choroidal vascular resistance (Riva et al., 1997b). 
Investigations in rabbits, in which systemic blood pressure had 
 been manipulated, demonstrated a nonlinear relationship between ChBF 
and PP suggesting that the choroid may well have some capability to 
autoregulate in this animal (Kiel and van Heuven, 1995). Not only rabbits 
exhibit some autoregulation in the choroid but also humans can do. Many 
investigators have suggested that the relationship between choroidal 
circulatory parameters and PP is not linear across the whole range of PP 
in normals due to some autoregulatory potency of the choroidal 
circulation (Hasler et al., 2002; Niknam et al., 2004; Riva et al., 1994; 
Riva et al., 1997c; Schocket et al., 2004).  
 
6.2. LDF data of POAG and OHT groups  
6.2.1. LDF data of POAG compared to controls 
To our knowledge, only few studies have been conducted to detect 
the subfoveal ChBF in glaucomatous patients using LDF technique. Our 
data demonstrated that all LDF parameters are significantly lower with 
increased R in the glaucomatous patients compared with the control 
subjects. Reduced blood flow to the posterior pole of the glaucomatous 
eye has been reported by many authors using other different techniques 
for the assessment of ChBF (Agarwal et al., 2003; Duijm et al., 1997; 
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Fuchsjager-Mayrl et al., 2004; Kerr et al., 1998; Nicolela et al., 1996b). 
On the other hand, it was revealed that the ChBF measurements obtained 
in the foveola of glaucomatous eyes were no significantly different from 
those of normals (Grunwald et al., 1998b). However, the authors 
mentioned that the small sample size (19 patients) in this study might be 
too small to demonstrate significance.   
The possible hemodynamic effect of the antiglaucoma medication 
on choroidal circulation should be considered in HTG patients. However, 
most of NTG patients were not yet under medications.  In spite of this 
fact, the two subgroups (HTG and NTG) showed a similar reduction of 
the LDF parameters, suggesting that the choroidal circulatory alterations 
are not related to the drug effects. This suggestion is supported by other 
studies demonstrating no significant difference in ChBF between treated 
and untreated glaucoma subjects (Fuchsjager-Mayrl et al., 2004; Zeitz et 
al., 2004), which assumed that the vascular changes in glaucoma are 
more likely a result of the glaucomatous process rather than of its 
treatment. However, the possible vascular effect of the anti glaucoma 
drugs on the ChBF is still a matter of debate and needs to be further 
clarified.  
6.2.2. LDF data of OHT compared to the controls and POAG 
patients   
The studies of ocular hemodynamic in OHT patients show 
conflicting results. Some studies agree with our results, demonstrating a 
significant reduction of ChBF in OHT patients compared to normal 
subjects with no significant difference in measurements between OHT 
and POAG patients (Fuchsjager-Mayrl et al., 2004; Kerr et al., 2003). 
Other studies found POBF (Kerr et al., 1998; Trew and Smith, 1991) and 
posterior ciliary artery (PCA) circulation (Akarsu and Bilgili, 2004) did 
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not differ significantly between normotensive and ocular hypertensive 
groups. These studies revealed a significant difference in the choroidal 
circulatory parameters between OHT and glaucoma groups. 
In summary, the findings of our study support the assumption that 
choroidal vascular abnormalities are an early event in the process of 
glaucoma and hence, the importance of monitoring closely the OHT 
patients whose IOP over 25 mmHg as they may get benefit from the 
prophylactic treatment of lowering the IOP (Fuchsjager-Mayrl et al., 
2004). 
6.2.4. Correlations between each of LDF parameters and IOP, 
PP, respectively, in POAG and OHT patients 
 
The data of the study showed no significant correlation between 
each of the subfoveal LDF parameters and any of the independent 
variables (IOP and PP) neither in the glaucoma group nor in the OHT one 
(see table 5 and 6, page 45). Therefore, factors other than IOP elevation 
or PP reduction must be involved in the initiation and progression of the 
vascular dysregulation in glaucoma, especially if we know that the 
ischemic damage of the neurons in the CNS is histopathologically similar 
to changes seen in glaucoma. Further, glaucoma patients with normal IOP 
show clear evidence for cerebral and ocular ischemia (Harris et al., 
2001). The results of the present study also support the hypothesis that 
assumes some autoregulation in patients with POAG during a moderate 
increase in IOP (Weigert et al., 2005). 
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6.3. LDF data of diabetic patients 
6.3.1. LDF data of diabetic patients without POAG 
Our findings are in agreement with other studies demonstrating 
significant  reduction of choroidal LDF parameters in patients with non 
diabetic retinopathy (NDR), non proliferative diabetic retinopathy 
(NPDR) (Nagaoka et al., 2004) and proliferative diabetic retinopathy 
(PDR) (Schocket et al., 2004).  As the measurements obtained by LDF 
correspond primarily to determination of choriocapillary flow, our 
findings of decreased ChBF values obtained in the NDR group suggest 
that the circulatory changes in the choriocapillaris may occur before the 
clinical manifestations of DR. Previous histopathological studies 
demonstrated the dropout of the choriocapillaris in diabetic eyes which 
could increase vascular resistance resulting in decreased blood flow in the 
choriocapillaris (McLeod and Lutty, 1994). 
The results of studies concerning the effect of severity of DM on 
the choroidal hemodynamics are conflicting. POBF was reported to 
decrease (Langham et al., 1991) or increase significantly with the severity 
of retinopathy (Findl et al., 2000). A recent study demonstrated no 
significant changes in PCA circulation measured by CDI with the 
progression of DR (Dimitrova et al., 2003). Although there was tendency 
of the LDF parameters to decrease and R to increase with progression of 
diabetes, no significant difference was demonstrated in the LDF 
parameters among diabetic patients with different grades of retinopathy 
(see table 10, page 48). Also we did not find a significant correlation 
between subfoveal ChBF and the duration of DM (see figure 18, page 
49). 
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6.3.2. LDF data of diabetic patients with POAG 
Compared to non diabetic glaucomatous patients, the diabetic 
patients with POAG show statistically significant reduction of the ChBF 
and increased R (see table 9, page 48). To our knowledge, no studies have 
been conducted to assess the subfoveal choroidal circulation in diabetic 
patients with glaucoma. However, the speed of blood perfusion and the 
pulsation curve in ciliary arteries were measured using Doppler 
ultrasonography in patients treated for glaucoma and diabetes. It was 
assumed that the increase of the IOP reveals a larger and earlier 
impairment of the regulating mechanism of the ciliary microcirculation in 
diabetic patients with glaucoma in comparison with the group of 
glaucomatous patients without diabetes (Augustyniak and Swietliczko, 
1991). 
The biological mechanism by which DM can affect the 
glaucomatous process is still unclear. The effect of diabetes on small 
blood vessel disease or systemic blood abnormalities can result in 
compromised vascular perfusion to the optic nerve, which increases the 
risk of GON (Wilson and Martone, 1996). Although epidemiological 
studies have not reached firm conclusions, recent basic studies strongly 
indicate that diabetes could be a risk factor of GON by compromising the 
glial and neuronal activities of the retina (Nakamura et al., 2005).  
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6.4. LDF data of hypertensive patients 
 
6.4.1. LDF data of hypertensive patients without POAG 
In the current study, we demonstrated that LDF parameters are 
significantly decreased and R is increased in hypertensive patients, under 
antihypertensive therapy, when compared with age matched controls (see 
table 13, page 50). These findings do not agree with the results of a recent 
study measuring the choroidal LDF parameters in hypertensive patients 
controlled by antihypertensive therapy. The authors assumed that SHT 
does not seem to have a significant effect on the choroidal circulation in 
those patients. They mentioned that the small sample size (15 patients) 
might not be able to give a strong conclusion (Niknam et al., 2004). 
However, further studies are needed to examine whether SHT or its 
treatment have an effect on the ChBF of hypertensive patients.  
6.4.2. LDF data of hypertensive patients with POAG 
To our knowledge, assessment of choroidal blood flow in 
glaucoma patients with SHT has not been previously reported. We found 
that there is no significant difference in the LDF parameters between 
hypertensive patients (under medical therapy) without and with 
glaucoma. These finding may assume persistence of some regulatory 
mechanisms in hypertensive patients in response to glaucoma. Compared 
with the glaucomatous group, the hypertensive patients with POAG, 
showed statistically significant reduction in the ChBF and increased R 
(see table 13, page 54). These results might suggest that SHT or 
antihypertensive therapy is an important systemic vascular risk factor that 
can lead to more vascular dysregualtion in glaucomatous eye.   
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6.5. LDF data of myopic subjects 
 
6.5.1 LDF data of myopic subjects without POAG 
A significant reduction of LDF parameters and increased R were 
demonstrated in myopic eyes when compared with the age matched 
controls (see table 15, page 51). ChBF was reported to decrease as the 
axial length increases using Langham ocular blood flow computerized 
tonometry (James et al., 1991). Another study reported a reduced PCA 
circulation in highly myopic patients (Akyol et al., 1996). The authors 
assumed that the reduced ChBF may be partly due to increased vascular 
resistance.  
The exact mechanisms underlying the development of myopia and 
myopic retinopathy are largely unknown. However, the altered ChBF in 
high myopia could have a role in the retinopathy that occurs in high 
myopia. Whether the reduced ChBF in high myopia is a result of axial 
elongation of the eyeball or could possibly be involved in the 
development of high myopia is not known.  
 
6.5.2. LDF data of myopic subjects with POAG 
To our knowledge, assessment of subfoveal ChBF in glaucoma 
patients with myopia has not been demonstrated in previous studies. 
However, studies of PCA velocities in myopic patients without and with 
POAG are conflicting. PCA velocities were demonstrated to decrease 
similarly with no significant difference between both subgroups of 
myopic eyes (without and with glaucoma) (Galassi et al., 1998). On the 
other hand, PCA velocities were recorded to decrease significantly in 
myopic eyes with POAG  in comparison to myopic eyes without  POAG 
(Karczewicz and Modrzejewska, 2004). In the present study, no 
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significant difference was revealed in the LDF parameters between 
myopic patients without and with POAG. A significant reduction of the 
ChBVol and ChBF and increased R were noted in the group of myopia 
with POAG when compared with glaucomatous emmetropic patients (see 
table 15, page 51). 
One hypothesis suggested that in glaucoma patients, the longer the 
axial eye length and the thinner the ocular wall the more reduced the 
retinal and choroidal microcirculation. The reduced microcirculation 
found in myopic glaucomatous eyes might contribute to the development 
of glaucomatous damage in these eyes (Nemeth et al., 2001). 
 
6.6. Comparison of baseline LDF data of groups with 
various glaucoma risk factors. 
Finally, we compared the effects of the various studied risk factors 
(HTG, DM, SHT and myopia) on the choroidal hemodynamics.   
Diabetic and myopic patients showed the most marked reduction in 
the LDF parameters and increased R when compared with the 
glaucomatous group. On the other hand, there was no significant 
difference in ChBVel or ChBVol among the different groups (see table 
16, page 52). 
These results indicate that other factors, not necessary related to 
glaucoma, may influence ocular blood flow findings and therefore altered 
blood flow parameters may not necessary be associated with 
glaucomatous damage. As so many glaucoma patients have systemic 
diseases, care should be taken when relating reduced blood flow 
parameters to glaucomatous damage (Ferdinand et al., 1999). 
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7. Summary, Conclusions and Recommendations 
7.1. Summary 
Glaucomatous optic neuropathy (GON) is characterized by 
progressive loss of retinal ganglion cells, including their axons, and by 
tissue remodeling of the optic nerve head. This is followed by visual-field 
defects. Traditionally, diagnosis and treatment has been directed towards 
lowering the IOP, which has been considered the most important risk 
factor. However, not all patients with glaucomatous damage have an 
elevated IOP, and progression of GON may occur even at IOP in the low 
teens. These facts challenge the pathophysiological concept of glaucoma 
based only on IOP. Hence disturbed ocular blood flow has been regarded 
as a potential risk factor of great interest. 
In the present study, we have assessed the choroidal hemodynamic 
changes in glaucoma patients (high and normal tension glaucoma) and in 
patients with ocular hypertension. Also we have studied the effect of 
glaucoma risk factors on subfoveal choroidal circulation to determine its 
role in the pathogenesis of GON. Among the many risk factors described, 
DM, systemic hypertension (SHT) and myopia deserved special attention 
for the following reasons: 
  They are often associated with glaucoma. 
  Their role in glaucomatous damage or progression of the disease is 
controversial.  
  Control of DM and SHT may influence the progression of the disease. 
Furthermore, we studied the relations between the measured 
subfoveal choroidal hemodynamic parameters and certain clinical 
findings of glaucoma patients to determine the predictive role of theses 
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parameters in the diagnosis of glaucoma and assessment of its 
progression.  
The current study was carried out at the Geneva Ophthalmology 
Clinic, Switzerland. It included 389 patients (190 males and 199 females) 
whose age ranged from 14 to 90 years and the IOP from 10 to 28 mmHg.  
All patients were subjected to history taking with special attention to 
general medical history, full ophthalmological examination, including 
visual acuity (unaided and aided), refraction, applanation tonometry, 
anterior segment examination, gonioscopy and fundus examination. 
The subjects were classified into three main groups: 1) group of 
subjects with POAG or OHT, which further subdivided into three 
subgroups (HTG, NTG and OHT), 2) group of subjects with glaucoma 
risk factors which subdivided into diabetic, hypertensive and myopic 
subgroups. Subjects with each risk factor were further subdivided into 
two subgroups (without and with POAG), 3) group of age matched 
healthy controls. The subfoveal choroidal LDF parameters (ChBVel, 
ChBVol, and ChBF) and choroidal vascular resistance (R) were assessed 
in all subjects (see page 36). 
Summary of the results   
We studied baseline subfoveal choroidal LDF parameters and 
established correlations between these parameters and R, one side, and a 
number of characteristics (age, IOP, and PP) in the normal population, 
POAG and OHT patients on the other side. Apart from the positive 
correlation between PP and R in the normal population, we found no 
significant correlation between any of the three patients’ characteristics 
and either one of the LDF parameters, in any of the studied groups.                
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All LDF parameters were significantly reduced and the R was 
increased in the patients with HTG, NTG or OHT when compared with 
age matched controls, while there was no statistically significant 
difference in the LDF parameters among the three groups. Patients with 
glaucoma risk factors (diabetic, hypertensive, and myopic patients) 
revealed significant reduction of all measured LDF parameters and 
increased R when compared with the control group.  
Although there was a tendency of the LDF parameters to decrease 
and the R to increase in the more advanced diabetic stage, the difference 
did not reach the significant level among various grades of diabetic 
retinopathy. Similarly there was no significant difference in the choroidal 
LDF parameters between both types of diabetes. Moreover, no correlation 
was found between the duration of DM and ChBF. 
Analysis of the results of patients with glaucoma risk factors 
revealed, generally, no statistically significant difference in the LDF 
parameters between the two subgroup of each risk factor (without and 
with POAG). However, hypertensive patients with POAG showed 
significantly increased R in comparison with hypertensive patients 
without POAG.  
The LDF data of glaucomatous patients with risk factors 
demonstrated significant reductions of ChBF and increase of the R in 
comparison to glaucomatous patients without risk factors. In addition, 
significant reduction of the ChBVol was observed in myopic patients 
with glaucoma. 
Lastly, the collected data from patients with different risk factors 
(HTG, DM, hypertension and myopia) revealed that the reduction in 
ChBF and the increased R were most marked in diabetic and myopic 
patients when compared with the glaucomatous group. On the other hand 
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there was no significant difference in ChBVel and ChBVol among the 
different groups. 
 
7.2. Conclusions 
We may summarize our conclusions in the following points: 
1. The results of the current study clearly reveal alterations of the 
subfoveal choroidal LDF parameters in POAG and OHT patients. Theses 
alterations appear to be an early manifestation in glaucomatous patients. 
They are neither affected by IOP nor by pharmacological intervention, as 
we noted altered LDF parameters in patients with treated HTG, untreated 
NTG and OHT. 
2. The development of GON seems to be multifactorial. Combined 
occurrence of two or more risk factors such as slightly increased IOP 
together with myopia or DM might often leads to damage much more 
than occurred by marked IOP elevation alone. In the current study, 
glaucomatous patients with risk factors such as DM, SHT, or myopia 
reveal significant reductions of ChBF and increase of the R in 
comparison to glaucomatous patients without risk factors (see tables 9, 
13, and 15, pages 48, 50 and 51). Such data suggest that the impaired 
choroidal circulation caused by these risk factors might be an important 
additional risk factor involved in the glaucomatous damaging process. 
3. Other factors, not necessarily related to glaucoma may alter the 
choroidal LDF parameters. In other words, not all the cases of altered 
ocular blood flow develop GON. Therefore other factors, besides 
vascular insufficiency, seem to be responsible for the glaucomatous 
damage.  
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4. Although our present study cannot comprehensively address the 
nature of the mechanisms controlling subfoveal choroidal blood flow, it is 
nonetheless evident from our findings that an increase in the PP is not 
accompanied by an equivalent increase in ChBF. Also there was no 
significant difference in most of the LDF parameters between the risky 
patients without and with glaucoma. These data strongly support the 
presence of some blood flow autoregulation in the human choroid. 
Previous studies suggest a neural or passive process rather than a 
myogenic or metabolic mechanism (Riva et al., 1997c). Also, it is evident 
that this autoregulatory mechanism is also present in old age subjects, 
POAG, and OHT patients. 
5. Our data support the contention that significant changes in choroidal 
microcirculation occur during the pathogenesis of diabetic retinopathy, 
even before the appearance of the signs of retinopathy.  
6. Our findings may raise concerns that SHT or antihypertensive drugs 
may affect the choroidal blood flow leading to compromised ocular 
perfusion which may be a risk factor for GON. 
7. Although LDF does not provide absolute measurements of flow, it is 
noninvasive method that appears to provide continuous and sensitive 
measurements of relative choroidal blood flow in the foveal region of the 
human fundus. Therefore, LDF can be considered to be an attractive non-
invasive tool for investigation of the alterations in the choroidal 
circulation in physiological and many pathological conditions. 
8. However, validation and interpretation of the published data are 
difficult. Also, it remains unclear wither alterations of ChBF just 
accompany the GON or encroach on axonal survival of the optic nerve. In 
addition, the influence of additional factors such as sex, plasma levels of 
endothelin, and systemic blood pressure remains to be clarified.  
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Nevertheless, there is overwhelming evidence that subfoveal 
choroidal blood flow in patients with GON is altered. Thus, vascular 
evaluation seems to be meaningful for glaucoma patients whose disease 
progresses despite controlled IOP.  
7.3. Recommendations 
 
Due to the fact that we are dealing with multifactorial disease, it is 
more meaningful in the clinical practice to proceed as follows: 
 Quantification of glaucomatous damage. 
   Analysis of risk factors which might have contributed to such damage. 
   Initiation of the treatment according to weighting of associated risk 
  factors. 
Much further researches are needed for the following purposes: 
 Better understanding of the pathogenic mechanism and how it may be 
different in various cases. This is needed to predict more successfully 
an individual’s risk of glaucomatous damage, to make decisions about 
the aggressiveness of treatment, and one day to direct therapy at the 
type of vascular abnormality present in addition to or instead of 
lowering IOP. 
 Confirmation of the predictive and prognostic values of reduced 
choroidal hemodynamic in glaucomatous process. 
 Understanding of the physiology of vascular regulatory mechanism in 
different parts of the eye. 
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